These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29315282)

  • 41. New drug helps relieve chemotherapy-related symptoms.
    FDA Consum; 2003; 37(4):3. PubMed ID: 12971326
    [No Abstract]   [Full Text] [Related]  

  • 42. [A guideline for antimetics use for patients with malignancies].
    Horie Y; Boku N
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1163-8. PubMed ID: 22902437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dronabinol and nabilone ease cancer chemotherapy.
    Manzo M
    Nursing; 1988 Aug; 18(8):81. PubMed ID: 2839807
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of navoban for nausea and vomiting caused by chemotherapy for malignant tumors].
    Seliuzhitskiĭ IV; Temerin KA; Feofanov VP
    Vopr Onkol; 1994; 40(4-6):225-7. PubMed ID: 7785250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiemetic effectiveness and nausea and vomiting incidence during capecitabine and oxaliplatin chemotherapy.
    Chan A; Tan SH; Low XH; Yap KY
    Nurs Res; 2012; 61(6):405-12. PubMed ID: 22960588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlling emesis: what is it worth?
    Fox SC
    J Clin Oncol; 2006 Dec; 24(35):5617; author reply 5616-7. PubMed ID: 17158553
    [No Abstract]   [Full Text] [Related]  

  • 48. [Anti-emetics in oncology].
    Mahjoubi M; Lopez C; Pallard MC; Droz JP
    Rev Infirm; 1990 Dec; 40(19):35-7. PubMed ID: 2091208
    [No Abstract]   [Full Text] [Related]  

  • 49. [ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting].
    Longo F; Mansueto G; Magnolfi E
    Tumori; 2006; 92(1):suppl 24-31. PubMed ID: 16683393
    [No Abstract]   [Full Text] [Related]  

  • 50. [Nausea and vomiting induced by chemotherapy].
    Scotté F; Chastenet M; Leroy P; Aumont L; Goudiaby C; Legeay K; Beuzeboc P
    Rev Prat; 2019 Jan; 69(1):49-54. PubMed ID: 30983284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevention and therapy of cytostatic-induced vomiting].
    Riess H; Ludat K
    Dtsch Med Wochenschr; 1991 May; 116(18):705-12. PubMed ID: 2026101
    [No Abstract]   [Full Text] [Related]  

  • 52. ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV).
    Herrstedt J; Aapro MS; Roila F; Kataja VV;
    Ann Oncol; 2005; 16 Suppl 1():i77-9. PubMed ID: 15888767
    [No Abstract]   [Full Text] [Related]  

  • 53. The difficult trials.
    Herrstedt J
    Onkologie; 2009 Feb; 32(1-2):7-8. PubMed ID: 19209012
    [No Abstract]   [Full Text] [Related]  

  • 54. Chemotherapy. An overview of nausea and vomiting in the cancer patient: etiology and management of serious complications of chemotherapy.
    Needleman R
    AAOHN J; 1987 Apr; 35(4):179-82. PubMed ID: 2950890
    [No Abstract]   [Full Text] [Related]  

  • 55. Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy.
    Falkson CI; Falkson HC
    Oncology; 1995; 52(5):427-31. PubMed ID: 7637962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].
    Nieber K; Schoppmeyer K
    Pharm Unserer Zeit; 2007; 36(5):373-80. PubMed ID: 17722144
    [No Abstract]   [Full Text] [Related]  

  • 57. Cipropride in preventing nausea and vomiting induced by severely emetic cytostatic agents.
    Serrou B; Cupissol D; Rosenfeld C; Metz R; Coquelin JP; Sauvanet JP
    J Int Med Res; 1981; 9(5):390-1. PubMed ID: 7197651
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients.
    Scher CS; Amar D; McDowall RH; Barst SM
    Can J Anaesth; 1992 Feb; 39(2):170-2. PubMed ID: 1544199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experience with the clinical use of navoban].
    Voznyĭ EK; Dobrovol'skaia NI; Volkova LA
    Vopr Onkol; 1995; 41(1):70-1. PubMed ID: 7667947
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparative evaluation of 2 antiemesis tools for the prevention of chemotherapy-induced nausea and vomiting].
    Murata H; Teramoto Y; Kawashita M; Oi M; Kitaguchi T; Sasahira E; Masuda A; Satake Y; Enomoto S; Komai C; Udo M; Komuta K; Yamamoto K
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):341-5. PubMed ID: 24743280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.